Ipca Laboratories Limited (NSEI: IPCALAB)
Health Care · Pharmaceuticals · IN
Rs1,915.40
-1.43% today · +43.5% 1Y
Ipca Laboratories Limited (NSEI: IPCALAB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.02B and employs 17,210 people.
Over the last twelve months the share price has gained 43.5%, trading between 1.25K and 2.04K.
Tweenvest scores Ipca Laboratories Limited across four factors: quality 82/100, value 34/100, growth 68/100, dividend 69/100. Its strongest factor is quality.
IPCALAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.02B
- Revenue (TTM)
- $1.07B
- P/E
- 37.10
- EPS
- 51.63
- Dividend yield
- 0.31%
- Beta (5Y)
- 0.04
- 52-week high
- Rs2,038.00
- 52-week low
- Rs1,251.60
- Avg volume (3M)
- —
- Shares outstanding
- 253.70M
- Employees
- 17,210
- Next earnings
- —
About Ipca Laboratories Limited
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
- ISIN
- INE571A01038
- Founded
- 1949
- Listed since
- Jan 1, 1996
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai Allist Pharmaceuticals Co., Ltd.SHSE: 688578 | $5.54B | CN¥82.50 | -26.06% |
| Veradermics, IncorporatedNYSE: MANE | $5.47B | $125.45 | -4.17% |
| Gland Pharma LimitedNSEI: GLAND | $5.22B | Rs3,061.80 | +6.52% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd.SZSE: 002294 | $5.12B | CN¥30.93 | +0.88% |
| Beijing Tongrentang Co., LtdSHSE: 600085 | $4.97B | CN¥24.28 | +2.27% |
| Definium Therapeutics, Inc.NasdaqGS: DFTX | $4.96B | $35.04 | -5.04% |
| Humanwell Healthcare (Group) Co.,Ltd.SHSE: 600079 | $4.69B | CN¥19.23 | +0.31% |
| Hanmi Pharm. Co., Ltd.KOSE: A128940 | $4.54B | ₩480,500.00 | -5.04% |
Figures last refreshed Oct 11, 2026.